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EFFECT OF PREDNISONE ON SEBACEOTJS GLAND SECRETION*
PETER E. POCHI, M.D. AND JOHN S. STRAUSS, M.D.
In a previous investigation of the role of
adrenoeortieal hormones on sebaceous gland
activity in man, We reported that prednisone
Was unable to stimulate sebaceous gland secre-
tion Which had been suppressed by estrogen
administration and thus lacked an androgen-
like effect (1). In the same study it Was found
that the administration of dehydroepiandros-
terone, the major adrenal androgen, could over-
come such estrogen suppression. This latter
finding suggested a possible role for adrenal
androgen in the maintenance of sebaeeous
gland function. The present report Will de-
scribe observations on the effect of adreno-
cortical suppression on sebum production from
the experimental administration of prednisone
to various groups of subjects.
MATERIALS AND METHODs
Prednisonet was administered orally to the fol-
lowing groups of subjectst:(a) seven normal male subjects, age 23—45. Five
subjects received 20 mg daily for 10 weeks and a
reduced withdrawal dosage for 2 subsequent weeks.
Two other subjects were given 10 mg daily for 10
weeks and reduced dosages for one additional week.
(b) twelve normal female subjects, age 18—28.
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Eight subjects received 20 mg daily for 8 weeks
and smaller dosages subsequently over a 2 to 3—
week period. Four other individuals were adminis-
tered 10 mg of prednisone daily for 10 weeks and
a reduced amount of drug for one further week.
(c) eight castrated male subjects, age 37—48, who
received 20 mg daily of prednisone for a period of
S weeks.
Sebum production was measured in all individ-
uals by a method described previously (2). In the
female subjects and in the intact male group, 3 to
8 sebum production tests were done before pred-
nisone was begun, and then a sebum test was per-
formed approximately weekly during the total pe-
riod of drug administration. In the castrated male
subjects, 3—4 tests were carried out before pred—
nisone was begun, and a similar number of meas-
urements were made at the end of the drug pe-
riod.
In 3 of the castrate subjects 24-hour urinary
specimens were analyzed for their total 17-keto-
steroid content by the method of Drekter et al (3),
before and at the end of prednisone administra-
tion.
nasuLTs
The results obtained from the effect of
prednisone administration on sebum pro-
duction appear in Table I (normal males),
Table II (normal females) and Table III (cas-
trated males). In the subjects in whom sebum
production was measured weekly, preliminary
analysis of the data revealed that when sup-
pression of sebum production occurred, the
response did not usually become evident until
several weeks had elapsed. Therefore, the mean
sebum value resulting from prednisone ad-
ministration was determined for the subjects
tested weekly as the average of all test values
obtained after the sixth week of drug adminis-
tration.
In the intact males no significant suppres-
sion of sebum production was seen from pred-
nisone administration in any of the 7 subjects
studied. In the 12 female subjects a 19 per cent
mean reduction in sebum secretion was ob-
served (p < .01) even though four of the sub-
jects failed to show any significant change. In
the women who received 20 mg daily, the
average per cent suppression was 21 per cent,
compared to 14 per cent for those adminis-
tered 10 mg daily. In the castrated males there
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TABLE I
Effect of prednisone on sebum production (mg/1O cm2/3 hr) in normal adult males
Daily dose
20mg
Subject
1
2
3
4
5
Mean pre-
treatment
Weeks Mean
treatment
sebum
2.98
2.28
3.30
2.02
1.56
Per cent
suppres-
sion
7%
3%
None
None
None
sebum
3.19
2.36
2.93
1.89
1.41
1
3.69
2.60
3.19
2.10
1.80
2
4.27
1.83
3.65
1.44
1.69
3
3.91
3.31
—
2.07
1.76
4
3.22
3.71
3.00
1.85
1.64
5
3.19
2.67
3.49
1.61
1.63
6
3.10
2.48
3.21
1.83
1.30
7
3.32
2.38
3.66
2.66
1.92
8
2.95
2.76
3.12
1.42
1.60
9
3.44
2.50
3.49
2.14
1.30
10
2.35
1.79
2.98
1.76
1.39
11
2.50
2.11
3.26
1.80
1.44
12
3.29
2.14
—
2.35
1.73
10mg 6
7
2.82
2.57
2.57
2.93
2.05
2.36
2.90
2.36
2.69
2.13
2.25
2.47
2.67
3.26
2.90
2.33
2.91
2.90
2.98
2.85
2.82
—
2.31
2.78
—
—
2.78
2.72
2%
None
* Average of all sebum values after 6th week of drug administration.
TABLE II
Effect of prednisone on sebum production (mg/b cmt/3 hr) in normal adult females
Daily dose Subject
Mean pre-
tre:tment
Weeks Mean
treatment
suppression
1 2 3 4 5 6 7 8 9 10
20mg 1
2
3
4
5
6
7
8
3.78
1.18
2.30
1.80
3.43
1.22
3.78
1.16
—
0.97
2.32
1.78
3.50
1.92
—
1.18
2.86
1.01
1.70
—
3.00
1.49
3.35
1.32
4.34
1.32
2.38
—
3.80
0.99
4.66
1.14
4.36
1.88
1.57
1.20
2.32
1.18
4.03
1.22
4.10
1.01
1.76
1.22
2.45
1.63
3.04
1.74
2.34
1.30
2.13
1.40
2.56
1.03
2.96
1.59
3.45
0.68
1.51
1.22
3.04
1.22
—
1.20
2.17
0.72
1.61
1.61
2.19
0.99
4.21
0.64
2.79
1.07
2.11
1.36
2.73
1.14
3.02
1.61
1.36
1.09
—
1.30
2.65
1.07
3.20
1.20
0.97
—
—
—
—
0.54
—
—
2.15
0.89
1.74
1.37
2.65
0.99
3.48
1.16
43%
25%
24%
24%
23%
19%
8%
None
10mg 9
10
11
12
3.54
2.71
4.75
2.90
3.58
2.94
4.53
2.22
2.50
1.99
4.15
3.27
3.31
2.24
—
2.86
2.11
1.88
4.78
—
—
—
—
4.82
3.02
2.81
5.04
3.02
—
3.20
5.36
2.62
2.07
2.34
4.51
2.90
2.01
2.15
4.13
2.54
2.94
1.20
—
4.23
2.21
—
4.30
—
2.31
2.22
4.58
3.07
35%
18%
4%
None
* Average of all sebum values after 6th week of drug administration.
occurred a considerably greater degree of se-
baceous gland inhibition from the effect of
prednisone. All but one of the 8 subjects showed
a significant fall in sebum output, with an
average group reduction of 40 per cent.
Table IV lists the results of total urinary
17-ketosteroid excretion in 3 castrated males
before and after prednisone administration.
In each subject a significant suppression of
17-ketosteroid excretion was observed.
DISCUSSION
In the present study no significant change in
sebum production occurred in the normal male
subjects following adrenocortical suppression
TABLE III
Effect of prednisone, O my daily for 8 weeks, on
sebum production (mg/b cm2/3 hr) in
adult male castrates
Subject Mean pretreat-ment sebum Mean treatmentsebum Per centsuppression
1 3.94 1.40 65%
2 1.23 0.53 57%
3 1.54 0.74 52%
4 2.42 1.32 45%
5 1.69 0.98 42%
6 1.27 0.91 28%
7 1.12 0.89 21%
8 1.53 1.43 7%
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TABLE IV
Total urinary 17-ketosteroid excretion in male
castrates before and after prednisone
administration
Subject
17-Ketosteroids (mg/24 hr)
Control Prednisone
1
4
7
13
10
11
7
6
4
with prednisone. The likely explanation for
the failure of this group to respond is that the
stimulatory effect of testicular androgen ob-
scures any possible effect on the sebaceous
gland from suppression of adrenal androgen
output. However, in the castrated male sub-
jects a marked fall in sebum production was
seen. In these individuals who lack testicular
androgen, sebaccous gland activity appears to
be dependent upon stimulation by adrenal
androgen (4). The observed reduction by pred-
nisonc of the excretion of 17-ketosteroids,
which in castrates are solely of adrenal origin
and which consist in part of androgenic
steroids such as dehydrocpiandrostcrone, is
consistent with this view.
The significant although somewhat variable
suppression of scbum output in females from
adrenocortical-suppressive doses of prednisone
suggests that sebaccous gland activity in
women is under the influence of adrenal an-
drogen. In a prior study we showed that scba-
ceous gland secretion in adult premenopausal
women exceeds that of similarly-aged castrated
males (4). From this observation it may be
reasoned that the female has in addition to the
adrenal cortex a further source of androgen
and that this is most likely the ovary. Thus,
it would appear that sebaceous gland activity
in the female is the result of stimulation by
both adrenal and ovarian androgen.
Heite and Strcckhardt have reported a re-
duction in sebaceous gland size histologically
in patients with various skin disorders re-
ceiving prednisolone orally in doses of 15 to
40 mg daily (5). Their findings differ from
those we report here in that sebaceous gland
inhibition was observed in 10—28 days and
occurred in men as well as in women. Not only
did we fail to see any significant suppression
of the sebaceous gland in normal men, but we
were also unable to detect any inhibitory ef-
fect in the early weeks of prednisone admin-
istration. One possible explanation for these
discrepant findings is that Heite and Streck-
hardt studied patients with chronic skin con-
ditions whereas our observations were made
in normal subjects.
In our interpretation of the effect of pred-
nisone on sebaccous gland secretion in the
various groups studied, we make the assump-
tion that the exogenous administration of
prednisonc in doses of 10—20 mg daily would
not affect the sebaccous gland other than by
suppression of the pituitary-adrenocortical
pathway. However, the possibility of other
mechanisms of actions cannot be absolutely
excluded. For example, studies in rats have
shown that the local application of cortisol or
prednisolone results in a reduction of seba-
ccous gland size which is confined to the area
of application (6). However, such a local sup-
pressive effect has not been demonstrated in
man.
SUMMARY
1. The effect of adrcnocortical-suppressive
doses of prednisone on sebum production was
studied in normal males, normal females, and
castrated males.
2. No suppression of sebaceous gland secre-
tion occurred in normal intact males from
prednisone administration. Female subjects
demonstrated a variable but significant re-
duction (average, 19 per cent) in sebum out-
put. Castrated males showed the highest de-
gree of sebum suppression (average, 40 per
cent).
3. The failure to observe sebaceous gland
inhibition in normal males from adrcnocorti-
cal-suppressive doses of prednisone is prob-
ably due to the overriding effect of stimulation
by testicular androgcn.
4. The finding of a significant reduction in
scbum secretion of normal females from pred-
nisone administration suggests a physiologic
role of adrenal androgens in women for the
stimulation of the androgen-sensitive seba-
ceous gland.
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